FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 14,360,522
- Share change
- -128,536
- Total reported value
- $87,742,748
- Price per share
- $6.11
- Number of holders
- 62
- Value change
- -$6,402,237
- Number of buys
- 38
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
4,077,214
|
$45,338,620 | — | 31 Mar 2024 | |
| Sonic GP LLC |
13F
|
Company |
7.1%
|
2,407,357
|
$26,769,810 | — | 31 Mar 2024 | |
| DG Capital Management, LLC |
13F
|
Company |
4.4%
|
1,511,663
|
$16,809,693 | — | 31 Mar 2024 | |
| Solas Capital Management, LLC |
13F
|
Company |
3.3%
|
1,110,233
|
$12,345,791 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,013,626
|
$11,271,521 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
927,466
|
$10,313,422 | — | 31 Mar 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.7%
|
570,332
|
$6,342,092 | — | 31 Mar 2024 | |
| HARBERT FUND ADVISORS, INC. |
13F
|
Company |
1.4%
|
466,869
|
$5,191,583 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.89%
|
303,519
|
$3,375,131 | — | 31 Mar 2024 | |
| Jeffrey L. Gendell |
13F
|
Individual |
0.89%
|
302,478
|
$3,363,555 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
219,754
|
$2,443,664 | — | 31 Mar 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.5%
|
170,000
|
$1,890,400 | — | 31 Mar 2024 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.42%
|
144,218
|
$1,603,704 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
139,900
|
$1,556,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.33%
|
114,068
|
$1,268,436 | — | 31 Mar 2024 | |
| Adrian Haigh |
3/4/5
|
CHIEF OPERATING OFFICER |
—
mixed-class rows
|
1,205,738
mixed-class rows
|
$832,168 | — | 16 May 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.22%
|
74,090
|
$823,880 | — | 31 Mar 2024 | |
| CIBC WORLD MARKET INC. |
13F
|
Company |
0.21%
|
70,065
|
$779,000 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
58,534
|
$650,898 | — | 31 Mar 2024 | |
| Legato Capital Management LLC |
13F
|
Company |
0.17%
|
57,121
|
$635,186 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
48,714
|
$541,700 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
48,122
|
$535,112 | — | 31 Mar 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.14%
|
48,108
|
$534,961 | — | 31 Mar 2024 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.14%
|
47,798
|
$531,514 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
43,091
|
$479,172 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
41,497
|
$461,447 | — | 31 Mar 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.12%
|
39,909
|
$444,000 | — | 31 Mar 2024 | |
| EUDAIMONIA ADVISORS LLC |
13F
|
Company |
0.1%
|
35,359
|
$393,192 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.1%
|
34,260
|
$380,971 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
33,694
|
$374,677 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.1%
|
32,769
|
$364,391 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
29,618
|
$329,352 | — | 31 Mar 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.08%
|
26,414
|
$293,724 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
26,006
|
$289,187 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
22,599
|
$251,301 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
20,123
|
$223,758 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
19,000
|
$211,280 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
16,479
|
$183,246 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
15,554
|
$172,961 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
12,876
|
$143,181 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
12,313
|
$136,921 | — | 31 Mar 2024 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.03%
|
10,327
|
$114,836 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
10,162
|
$112,999 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
9,823
|
$109,232 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
9,752
|
$108,442 | — | 31 Mar 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.03%
|
9,679
|
$107,630 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.03%
|
8,944
|
$99,457 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.03%
|
8,884
|
$98,790 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
6,019
|
$66,931 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.01%
|
5,053
|
$56,191 | — | 31 Mar 2024 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q2 2024
As of 30 Jun 2024,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,360,522 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Sonic GP LLC, DG Capital Management, LLC, Solas Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, HARBERT FUND ADVISORS, INC., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and GENDELL JEFFREY L.
This page lists
62
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
64
Q2 2024 holders
62
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.